A Yale School of Medicine team has created lists of criteria to help clinicians determine when next-generation sequencing ...

Bispecific antibodies show strong initial uptake in community settings for multiple myeloma treatment, particularly among ...

Patients with ER-positive/HER2-negative metastatic breast cancer who received elacestrant experienced a significant reduction ...

Patients with dry eye associated with contact lenses had significant improvement in visual acuity and their Ocular Surface ...

Innovations in rare blood disorders took center stage at the 2024 American Society of Hematology (ASH) Annual Meeting & ...

Conventional parameters for risk stratification prognosis for patients with low-risk myelodysplastic neoplasms, especially ...

War-related psychological stress was associated with increased MRI-detected disease activity in patients with multiple ...

Novel strategies in the VISIBLE trial set a new standard for recruiting and retaining diverse participants with skin of color ...

Komal Jhaveri, MD, FACP, breast oncologist and early drug development specialist at Memorial Sloan Kettering Cancer Center, ...

By reducing cytokine release syndrome and neurotoxicity, prophylactic tocilizumab could facilitate safe outpatient ...

Alice W. Lee, PhD, MPH, of California State University, Fullerton, discusses her study on ovarian cancer survival disparities ...

The recommendations for surveillance account for newly identified hematopoietic malignancy predispositions (HMP) and HMP ...